标签归档 武汉夜生活

General Secretary of the Supreme Leader stressed, "Expand foreign trade, cultivate new trade formats and new models, and promote the construction of a trade power." The outline of the 14th Five-Year Plan clearly puts forward "promoting the coordinated development of import and export", requiring "expanding the import of high-quality consumer goods, advanced technology, important equipment and energy resources", "optimizing the quality and structure of export commodities" and "guiding enterprises to deepen traditional export markets and expand emerging markets".

In the first year of the 14 th Five-Year Plan, the quality of China’s foreign trade has increased, achieving a good start.

"This is our latest CNC precision machining center, where raw materials go in and come out as finished products. The precision of holes and screws can be one percent of that of hair. " Hu Lijun, general manager of Zhejiang Cixi Boli Vehicle Co., Ltd. said that since this year, the production line has not stopped, and the order has been scheduled for April 2023.

Boli car owners want to produce high-grade bicycle brake systems, and the products are sold to Europe and South America. Affected by the COVID-19 epidemic, some countries encouraged people to travel by bike, which greatly increased the demand for bicycles. Now the company is running at full capacity, with a monthly output of 150,000 pieces, which still cannot meet the demand of foreign markets. The company’s output value last year was about 150 million yuan, and it is expected to exceed 200 million yuan this year.

"Grasping the current foreign trade business opportunities has benefited from the company’s continuous investment in product research and development and technological transformation in recent years." Hu Lijun said, "We invest more than 50% of our annual profits in research and development. Since last year, the company has invested more than 30 million yuan to transform equipment, reducing the product error rate to about one thousandth, which is at the leading level in the industry. "

According to the data released by the General Administration of Customs, in the first quarter, the total import and export value of China’s goods trade was 8.47 trillion yuan, an increase of 29.2% over the same period last year. Among them, exports were 4.61 trillion yuan, an increase of 38.7%; Imports reached 3.86 trillion yuan, up by 19.3%. In the first quarter, China’s import and export scale not only far exceeded the same period of last year, but also increased by 25.3% and 20.5% respectively compared with the same period of 2018 and 2019.

Foreign trade connects international and domestic markets and resources; The improvement of foreign trade can better smooth the domestic circulation, promote the domestic and international double circulation, and provide strong support for building a new development pattern.

Fill it up and cheer up. In the first year, the commerce, customs and other departments and localities conscientiously implemented the outline of the 14th Five-Year Plan, sought impetus from reform, sought vitality from innovation, actively responded to various unstable and uncertain factors in the international market, promoted the steady and high-quality development of foreign trade.

-expanding high-quality imports to meet domestic demand.

Hainan Duty Free Shop is popular! From February 11 to 17 this year, the sales of Hainan Island Duty Free Shop during the Spring Festival Golden Week in 7 days exceeded 1.5 billion yuan, which was fully doubled compared with the Spring Festival holiday in 2019.

In the middle of last year, the Ministry of Finance, the General Administration of Customs and the State Administration of Taxation issued an announcement to increase the duty-free shopping quota for tourists from outlying islands in Hainan to meet the demand for consumption upgrading. In 2021, all localities and departments will further reduce institutional costs, continue to expand imports of high-quality consumer goods, and promote diversification of import sources. At the same time, with the sustained and stable recovery of China’s economy, we will actively promote the import of high-tech products and energy and other basic materials. Customs data show that in the first quarter, China imported 155.27 billion integrated circuits, an increase of 33.6%; 139 million tons of crude oil, up by 9.5%; 1.436 million tons of copper, an increase of 11.7%.

-optimizing the commodity structure and increasing the added value of exports.

"We seized the consumer’s demand for home entertainment and launched new products with intelligent interaction and voice shopping functions, which suddenly became a fire in overseas markets!" The relevant person in charge of a technology company in Shenzhen said, "In the first two months of this year, the company’s exports reached 30 million US dollars. Electromechanical products such as smart speakers, vacuum cleaners, coffee machines, and electric hair clipper are highly sought after. "

This year, the Ministry of Commerce proposed to focus on the implementation of three major plans: excellent import and export, trade industry integration and smooth trade to ensure the stability and smoothness of the foreign trade industrial chain and supply chain; The General Administration of Customs has taken various measures to optimize supervision services and promote trade facilitation; The vast number of foreign trade enterprises highlight the core competitiveness of technology, brand and service, strive to optimize the quality and structure of export commodities, and cultivate new advantages in export competition. In the first quarter, China exported 2.78 trillion yuan of mechanical and electrical products, up 43%, accounting for 60.3% of the total export value, up 1.7 percentage points over the same period last year; Among them, the export of automatic data processing equipment and its parts, mobile phones and automobiles (including chassis) increased by 54.5%, 38.5% and 98.9% respectively.

-expanding emerging markets and enhancing the ability to resist risks.

Recently, 100 boxes of crisp dates with local characteristics produced and processed by Hebei Huanghua Tiantian Food Development Company were officially loaded and shipped, and sold to Brunei, a country along the Belt and Road Initiative, for the first time. "In the prevention and control of the epidemic, the relevant departments took the initiative to serve and visited the company many times to help us successfully explore new markets and stabilize foreign trade orders." The relevant person in charge of the company said.

At the beginning of this year, the Ministry of Commerce proposed the development of "Silk Road E-commerce", promoted the integration and development of new formats and new models such as cross-border e-commerce and jointly built the "Belt and Road", and added new momentum to the construction of trade corridors such as China-Europe trains and new land and sea passages. All localities, departments and related enterprises have further expanded the "friend circle" of economic and trade cooperation and continuously deepened economic and trade cooperation with countries along the "Belt and Road". In the first quarter, China imported and exported 2.5 trillion yuan to countries along the Belt and Road, an increase of 21.4%. Among them, imports and exports to Vietnam, Indonesia and Poland all achieved rapid growth.

-building an open highland and accelerating the development of new formats.

Not long ago, in Linyi Comprehensive Bonded Zone, Shandong Province, a batch of bonded R&D goods such as single-cell second-generation gel bead kits successfully entered the zone under the supervision of Linyi Customs, becoming the first bonded R&D project of genetic testing in Shandong Comprehensive Bonded Zone. "According to preliminary estimates, through bonded R&D business every year, light-related taxes can save hundreds of thousands of yuan, and our R&D motivation is stronger!" The person in charge of Shandong Kaihua Health Industry Company said.

Since the beginning of this year, the General Administration of Customs, together with relevant departments, has continuously expanded the policy functions of the comprehensive bonded zone, supported the construction of processing and manufacturing centers, R&D and design centers and logistics distribution centers, and accelerated the construction of a new highland for opening to the outside world. The Ministry of Commerce refines service measures, promotes enterprises in the cross-border e-commerce comprehensive test zone to integrate the whole chain of import, transaction and after-sales, and develops new foreign trade models and formats. All localities take the comprehensive bonded zone and cross-border e-commerce comprehensive test zone as platforms, actively attract leading enterprises to enter the zone, and drive the surrounding areas to gather upstream and downstream supporting enterprises. In the first quarter, the import and export of comprehensive bonded zone increased by 41.1%, the import and export of free trade pilot zone increased by 28.4%, and the import of duty-free goods in Hainan Free Trade Port increased by 162.5%.

"In the first quarter, China’s foreign trade achieved a high growth rate that has not been seen for many years, showing the strong resilience and vitality of China’s foreign trade." Liang Ming, director of the Foreign Trade Research Institute of the Research Institute of the Ministry of Commerce, said that it is necessary to scientifically analyze the foreign trade situation, correctly treat the fundamentals of foreign trade, seize opportunities and meet challenges, and promote the "good start" of foreign trade to become a year-round red and sustained red, so as to make greater contributions to speeding up the construction of a new development pattern with domestic macro-cycle as the main body and domestic and international dual-cycle promoting each other.(Reporter Du Haitao, Kelly, Gu Chun, Qi Zhiming, Luo Shanshan)

Source | Cybertron Author | Xiao Wan

The varieties of 42 enterprises passed the consistency evaluation, among which Huahai Pharmaceutical, Unacon and Yangzijiang Pharmaceutical were the top three, followed by Hengrui Pharma, Jingxin Pharmaceutical, Haosen Pharmaceutical and Zhengda Tianqing.

42 pharmaceutical companies have reviewed varieties.

Now in mid-November, the overall progress of consistency evaluation has become the most concerned topic for all pharmaceutical companies. A few days ago, according to the incomplete statistics of CyberBlue, a total of 107 product specifications passed the consistency evaluation, among which 42 enterprises passed the consistency evaluation (the number of branches passed was included in the head office).

In statistics, one product specification of 18 pharmaceutical companies passed the consistency evaluation; Two of the 10 pharmaceutical companies have passed the consistency evaluation; Three varieties of seven pharmaceutical companies have been evaluated; Four varieties of three pharmaceutical companies have been reviewed; Four pharmaceutical companies have more than five product specifications.

(Source: Cyberblue)

Among them, Zhejiang Huahai Pharmaceutical Co., Ltd. passed the consistency evaluation, while Yangzijiang Pharmaceutical Co., Ltd. and Unacon Co., Ltd. passed the consistency evaluation, and Hengrui Pharma Co., Ltd. passed the consistency evaluation. Zhejiang Jingxin Pharmaceutical, Haosen Pharmaceutical and Zhengda Tianqing all passed the consistency evaluation.

The consistency evaluation of Zhejiang Huahai Pharmaceutical, Yangzijiang Pharmaceutical and Unacon has made rapid progress.

(Source: Cyberblue)

Huahai Pharmaceutical Co., Ltd.: Consistency Evaluation of Overtaking in Curves

According to the annual report of Huahai Pharmaceutical, Huahai Pharmaceutical has invested more in the over-evaluation research and development of irbesartan tablets, fosinopril tablets, lisinopril tablets and losartan potassium tablets.

The annual report shows that in 2017, the company’s R&D expenditure was 438.2377 million yuan, a year-on-year increase of 20.38%, accounting for 8.76% of the operating income of that year. The main reason is that the company has continuously increased the declaration and conformity evaluation of domestic new products, increased the R&D investment in biopharmaceuticals, new drugs, first imitation drugs, innovative pharmaceutical preparations, and accelerated the declaration of new products and models in markets such as the United States and the European Union.

Compared with other enterprises with more varieties, Huahai Pharmaceutical is characterized by adopting the form of "overtaking in corners"

—— Its overseas drugs with quality regulations enter the domestic market through supplementary application for domestic listed varieties and direct application for four kinds of new drugs overseas, and only need to BE declared with overseas listed test data, which will greatly reduce the cost and time of declaration compared with similar products enterprises that need to do BE experiments in China.

For example, its valsartan tablet is the first oral preparation of Huahai Pharmaceutical, which has been listed in Europe and America, and it is deemed to have passed the consistency evaluation if it is declared with overseas data.

Cebolan made statistics on the disclosure announcement of Huahai Pharmaceutical. Except for its product "Voriconazole Tablets", its R&D cost is an important basis for the company’s sales pricing in the US market. The important cost data is corporate trade secrets, and the R&D investment data has not been disclosed.

The total R&D investment of the remaining 9 evaluated varieties of Huahai Pharmaceutical is 44.08 million.

Among them, valsartan tablets have the largest R&D investment of 16.6 million, followed by donepezil hydrochloride tablets with 9.25 million R&D investment.

(Source: Cyberblue)

Unacon: Both are the first enterprises that have been appraised.

According to the statistics of Cybertron, Unacon has passed 7 product specifications and 5 varieties.

Unacon’s semi-annual report shows that the company has been actively promoting consistency evaluation. At the same time, make full use of the opportunity brought by consistency evaluation, strive for greater market share for products, and establish strategic cooperation with core distributors to expand and sink the terminal market to primary medical institutions.

Unacon didn’t disclose its R&D expenses, but according to the statistics of Cybertron, all the evaluated varieties in Unacon were "enterprises that passed the conformity evaluation for the first time".

Metformin hydrochloride: According to the data, metformin, as the most widely used oral hypoglycemic agent in clinic, has been crowned as the "magic medicine". Therefore, according to the statistics of Medical Rubik’s Cube, as a 289 variety, there are as many as 130 drug approval numbers for metformin, including 116 metformin hydrochloride tablets, 8 metformin hydrochloride enteric-coated tablets, 4 metformin hydrochloride enteric-coated capsules and 2 metformin hydrochloride capsules. The consistency evaluation of metformin is bound to be a "drama".

Among them, Unacon submitted its domestic listing application on the condition of "listing in the United States". On July 24th, Unacon’s metformin hydrochloride tablets obtained the registration approval of CFDA, and were officially approved for listing, taking the lead in evaluating the consistency of metformin.

Paclitaxel for injection (albumin-bound): In July, Paclitaxel for injection (albumin-bound) produced in Unacon (trade name Ke Aili) has been included in the Catalogue of Listed Drugs in China. Ke Aili has completed the clinical BE test before applying for new drug registration, and it is deemed to have passed the consistency evaluation, so it can be used instead of the original research product. In this declaration, Unacon surpassed Hengrui, who is known as the "First Brother in R&D", and won the first imitation.

Captopril Tablets: On July 3rd, Captopril Tablets (25mg) produced by Unacon Ouyi Pharmaceutical Company passed the evaluation of the consistency of generic drug quality and efficacy. Unacon Ouyi Pharmaceutical Co., Ltd. became the first enterprise to pass the consistency evaluation of Captopril tablets.

Tramadol Hydrochloride Tablets: On May 21st, Unacon announced that the group’s "Chimet" (tramadol Hydrochloride Tablets (50mg)) has been approved by china food and drug administration to pass the consistency evaluation of generic drug quality and efficacy, becoming the first enterprise in China to pass the consistency evaluation of this variety. It is reported that tramadol Hydrochloride Tablets are one of the key products of the group’s analgesic drugs.

Azithromycin tablets: On April 12th, Unacon announced that the group "Weihong" (azithromycin tablets (0.25g and 0.5g)) had passed the consistency evaluation of generic drugs, becoming the first enterprise in China to pass the consistency evaluation. It is reported that azithromycin tablets are one of the key products of the group’s anti-infective drugs.

Yangzijiang Pharmaceutical: Sustained efforts in mid-2018

Up to now, according to the statistics of Cybertron, seven specifications and five varieties of Yangzijiang Pharmaceutical have passed the consistency evaluation, among which five varieties of amlodipine besylate tablets, montmorillonite powder, glimepiride tablets, enalapril maleate tablets and dexmedetomidine hydrochloride injection have been evaluated.

In the carding process, Ceibaran found that all the remaining varieties passed the consistency evaluation from June to September 2018 except Enalapril Maleate Tablets which were reviewed in September 2017, and Yangzijiang Pharmaceutical continued to exert its strength and continuously reviewed in mid-2018.

(Source: Cyberblue)

From this, it can be seen that the style of Yangzijiang Pharmaceutical Co., Ltd. is to accumulate wealth and make thin hair. At a certain stage, it will exert its strength and continuously evaluate many varieties. When the 289 deadline is coming, Yangzijiang may be accumulating strength and making a big move, which is worth looking forward to.

To sum up, 42 enterprises have varieties that have passed the consistency evaluation, among which Huahai Pharmaceutical, Unacon Pharmaceutical and Yangzijiang Pharmaceutical are the top three, followed by Hengrui Pharma Pharmaceutical, Jingxin Pharmaceutical, Haosen Pharmaceutical and Zhengda Tianqing, and the deadline of 289 is coming soon. All pharmaceutical companies should pay close attention to it.

Publicity of the bid-winning result of security outsourcing service project in financial outlets of Tongchuan Branch

(TenderNo.: SY2025-37/XBMH2025-076)

A, the winning bidder information:

Bid (package) [001] Security outsourcing service project of financial outlets of Tongchuan Branch:

中标人： 陕西京武保安服务有限公司(主供应商）?xa0;?xa0;  其他类型中标价：单价报价

中标人： 陕西汇丰保安服务有限公司（备选供应商）  其他类型中标价：单价报价

二、其他：

（一）陕西京武保安服务有限公司(主供应商）投标单价报价：8.4 元/工时，服务期：2 年。 （二）陕西汇丰保安服务有限公司（备选供应商）投标单价报价：8.43 元/工时，服务期：2 年.

三、监督部门

本招标项目的监督部门为中国邮政集团有限公司陕西省分公司纪委办公室。

四、联系方式

招 标 人：中国邮政集团有限公司陕西省分公司

地?xa0;  址：陕西省西安市高新区唐延路 5 号陕西省邮政大厦 联 系 人：文琰童

电?xa0;  话：029-88602048 电子邮件：/

招标代理机构：陕西西北民航工程咨询有限公司

地?xa0;  址： 西安市唐延路 3 号唐延国际中心 AB 座 8/9 层

联 系 人： 佘冰霞、张恒

电?xa0;  话： 029-88347987-8046

电子邮件： 745496892@qq.com